Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Mallinckrodt
Colorcon
Moodys
Medtronic

Last Updated: December 3, 2022

CLINICAL TRIALS PROFILE FOR NALBUPHINE


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Nalbuphine

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00155233 ↗ Interaction Between Nalbuphine and Morphine in PCA Unknown status National Taiwan University Hospital Phase 4 2005-01-01 1. Nalbuphine is opioid mu receptor antagonist and kappa receptor agonist 2. This study was designed to investigate the interaction between nalbuphine and morphine
NCT00200564 ↗ Ketamine and Postoperative Analgesia in Children Unknown status Nantes University Hospital Phase 4 2004-02-01 The benefit of small doses of ketamine has been demonstrated for postoperative analgesia in adults but remains unproved in children. The investigators' purpose is to evaluate the effects of continuous intravenous small doses of ketamine versus placebo to improve the quality of postoperative analgesia in children (6 months to 6 years of age). Caudal anesthesia is performed for intraoperative analgesia and all children receive paracetamol, a non-steroidal anti-inflammatory and continuous intravenous nalbuphine.
NCT00323154 ↗ Nalbuphine for the Treatment of Opioid Induced Pruritus in Children Completed University of British Columbia Phase 3 2004-03-01 Itching is a frequent and disturbing side effect of the use of pain medication such as morphine. In the post-operative period, it can be more distressing to pediatric patients than their pain. The current first line treatment, an antihistamine (Benadryl), has a low efficacy. This treatment causes sleepiness and may be dangerous when used in combination with other drugs. Nalbuphine has analgesic properties similar to morphine as well as the ability to reverse some morphine-induced side effects, such as respiratory depression and itching. Nalbuphine has been used effectively for patients undergoing Caesarean sections. However, the effectiveness of nalbuphine in the pediatric population has not been investigated. We want to determine the efficacy of nalbuphine in the treatment of itching after morphine for postoperative pain relief. We will use a novel method to measure the effect of the treatment using an intensity scale before and after the drug, to determine the intensity difference.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Nalbuphine

Condition Name

Condition Name for Nalbuphine
Intervention Trials
Pain, Postoperative 8
Postoperative Pain 7
Pain 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Nalbuphine
Intervention Trials
Pain, Postoperative 27
Pruritus 9
Postoperative Nausea and Vomiting 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Nalbuphine

Trials by Country

Trials by Country for Nalbuphine
Location Trials
United States 86
Egypt 28
China 19
Taiwan 13
Germany 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Nalbuphine
Location Trials
California 7
Ohio 5
New York 4
New Jersey 4
Massachusetts 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Nalbuphine

Clinical Trial Phase

Clinical Trial Phase for Nalbuphine
Clinical Trial Phase Trials
Phase 4 25
Phase 3 7
Phase 2/Phase 3 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Nalbuphine
Clinical Trial Phase Trials
Completed 45
Recruiting 17
Unknown status 16
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Nalbuphine

Sponsor Name

Sponsor Name for Nalbuphine
Sponsor Trials
Assiut University 10
Trevi Therapeutics 9
Cairo University 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Nalbuphine
Sponsor Trials
Other 89
Industry 17
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Medtronic
Dow
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.